Industry Leaders to Discuss the Future of Predictive Toxicology
London, United Kingdom, December 11, 2009 --(PR.com)-- www.predictivetoxicology.co.uk
IQPC has confirmed the attendance of 20 internationally renowned experts at their Predictive Toxicology Conference, taking place in London on 24th- 25th February 2010. High calibre professionals presenting at the event include:
- Dr Andrew Worth, Project Leader Computational Toxicology, Systems Toxicology Unit Institute for Health and Consumer Protection (IHCP), European Commission - Joint Research Centre
- Dr David Jones, Principle Scientific Officer, MHRA
- Dr Paul Hastwell, Senior Scientist, GlaxoSmithKline
- Dr Eric Blomme, Director of Investigative Toxicology, Abbott
- Dr Franck Atienzar- Head of In Vitro Toxicology Unit, UCB Pharma
- Dr Frank Bonner, Chief Executive, Stem Cells for Safer Medicines
20 Pre-clinical toxicology experts, including those above, will explore:
- The regulatory assessment of the use of Computational models including QSARs in Predictive Toxicology
- The benefits afforded through implementation of early Predictive Toxicology and in particular, the use of genotoxicity screening methods such as the GreenScreen
- The current approaches to predictive hepatotoxicity and how they can be implemented as part of an optimum strategy to effectively reduce late stage drug attrition and thus reduce development costs
- Best practice models for Predictive Toxicology, including hepatocyte cultures and zebrafish
- Future directions of stem cell models in Predictive Toxicology and approaches for their scale up and integration with other technologies
In addition, the delegation will be looking to address the current challenges and future outlook of Predictive Toxicology. Specifically, there will be a panel discussion on the future of Predictive Toxicology and also two interactive pre-conference workshops, one looking into the future prospect of Predictive Toxicology without animals and the other focusing on the potential of Stem Cells to revolutionise toxicity evaluation and risk assessment. In each speaker session, delegates will also have the opportunity to ask questions and explore the content of the talks in more detail.
www.predictivetoxicology.co.uk
###
IQPC has confirmed the attendance of 20 internationally renowned experts at their Predictive Toxicology Conference, taking place in London on 24th- 25th February 2010. High calibre professionals presenting at the event include:
- Dr Andrew Worth, Project Leader Computational Toxicology, Systems Toxicology Unit Institute for Health and Consumer Protection (IHCP), European Commission - Joint Research Centre
- Dr David Jones, Principle Scientific Officer, MHRA
- Dr Paul Hastwell, Senior Scientist, GlaxoSmithKline
- Dr Eric Blomme, Director of Investigative Toxicology, Abbott
- Dr Franck Atienzar- Head of In Vitro Toxicology Unit, UCB Pharma
- Dr Frank Bonner, Chief Executive, Stem Cells for Safer Medicines
20 Pre-clinical toxicology experts, including those above, will explore:
- The regulatory assessment of the use of Computational models including QSARs in Predictive Toxicology
- The benefits afforded through implementation of early Predictive Toxicology and in particular, the use of genotoxicity screening methods such as the GreenScreen
- The current approaches to predictive hepatotoxicity and how they can be implemented as part of an optimum strategy to effectively reduce late stage drug attrition and thus reduce development costs
- Best practice models for Predictive Toxicology, including hepatocyte cultures and zebrafish
- Future directions of stem cell models in Predictive Toxicology and approaches for their scale up and integration with other technologies
In addition, the delegation will be looking to address the current challenges and future outlook of Predictive Toxicology. Specifically, there will be a panel discussion on the future of Predictive Toxicology and also two interactive pre-conference workshops, one looking into the future prospect of Predictive Toxicology without animals and the other focusing on the potential of Stem Cells to revolutionise toxicity evaluation and risk assessment. In each speaker session, delegates will also have the opportunity to ask questions and explore the content of the talks in more detail.
www.predictivetoxicology.co.uk
###
Contact
IQPC
Jagruti Lachhani
+44 (0)20 7368 9300
www.predictivetoxicology.co.uk
Jagruti Lachhani
+44 (0)20 7368 9300
www.predictivetoxicology.co.uk
Contact
Categories